Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 2382

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 15
Chunk 2382
---
 giving effect to the Representative Affiliate Transactions (as defined below), which it intended to use primarily
for general corporate purposes and expenses associated with the IPO.

Recission
Agreement

On
February 10, 2024, the Company entered into a Stock Rescission Agreement with certain affiliates of A.G.P. pursuant to which the
Company rescinded 111,129 shares of Common Stock held by such affiliates of A.G.P. and agreed to refund an aggregate
of $91,512 paid by such affiliates of A.G.P. in consideration therefor within 30 days of the effective date of the Stock
Rescission Agreement. At December 31, 2024, all such amounts have been paid pursuant to the Representative Affiliate Transactions
and there are no remaining obligations thereto.

Equity
Issuances

On
June 12, 2024, the Company issued 50,000 shares of Common Stock to a vendor in considerations for the services provided
by the vendor to the Company.

On
June 12, 2024, the Company entered into a twelve-month agreement with a vendor to issue up to 7,500 share of Common
Stock per month for services performed by such vendor. As of December 31, 2024, the Company has issued 51,187 shares
of Common Stock pursuant to this agreement.

On
August 12, 2024, the Company issued 10,000 shares of Common Stock to a vendor in exchange for outstanding invoices related
to services provided by the vendor to the Company, with such shares issued on October 22, 2024.

On
October 22, 2024, the Company issued 50,000 shares of Common Stock to a vendor in considerations for the services provided
by the vendor to the Company.

On
November 18, 2024, the Company issued 25,000 shares of Common Stock to a vendor in considerations for the services provided
by the vendor to the Company.

During
the year ended December 31, 2024, the Company issued 16,667 shares of Common Stock to a vendor in considerations for
the services provided by the vendor to the Company, with such shares granted on October 22, 2024.

Committed
Equity Financing

On
July 26, 2024, the Company entered into a Common Stock Purchase Agreement, dated as of July 26, 2024 (the “CEF